Planet 13 Holdings PLNH
OTC PLNH
$0.16 +0.01 (+5.63%)
As of: Aug 21, 2026 · 3:59 PM EDT

Planet 13 Holdings (PLNH) Cash & Current Investments (2020 - 2026)

Planet 13 Holdings (PLNH) posted quarterly Cash & Current Investments of $16.3 million for Q1 2026, down 7.67% year-over-year from $17.6 million in Q1 2025, and up 4.38% quarter-over-quarter from $15.6 million in Q4 2025.

Planet 13 Holdings (PLNH) Cash & Current Investments (2020 - 2026) Analysis & Trends

Planet 13 Holdings (PLNH) has reported Cash & Current Investments for 7 consecutive years, with $16.3 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Cash & Current Investments fell 7.67% year-over-year to $16.3 million; the TTM figure through Mar 2026 stood at $16.3 million (down 7.67% YoY), while the FY2025 annual figure was $15.6 million, down 38.77% from the prior year.
  • Cash & Current Investments advanced to $16.3 million in Q1 2026 per PLNH's latest filing, from $15.6 million in the prior quarter.
  • Across five years, Cash & Current Investments topped out at $62.1 million in Q1 2022 and bottomed at $15.6 million in Q4 2025.
  • Historically, Cash & Current Investments has averaged $28.4 million across 5 years, with a median of $24.5 million in 2023.
  • On a YoY basis, Cash & Current Investments climbed as much as 37349.39% in 2022 and fell as far as 61.39% in 2022.
  • Planet 13 Holdings' Cash & Current Investments stood at $38.8 million in 2022, then tumbled by 55.45% to $17.3 million in 2023, then soared by 47.18% to $25.4 million in 2024, then sank by 38.77% to $15.6 million in 2025, then climbed by 4.38% to $16.3 million in 2026.
  • Business Quant data shows PLNH's Cash & Current Investments at $16.3 million in Q1 2026, $15.6 million in Q4 2025, and $17.2 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Haleon 44.51 Bn 43.55 Bn - 963.33 Mn
2 Teva Pharmaceutical Industries 43.52 Bn 39.86 Bn 2.15 Bn 3.66 Bn
3 Zoetis 32.43 Bn 30.75 Bn 1.05 Bn 1.68 Bn
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn 5.80 Bn
5 United Therapeutics 21.87 Bn 19.21 Bn 683.80 Mn 2.66 Bn
6 Viatris 18.98 Bn 18.09 Bn 1.46 Bn 886.50 Mn
7 Neurocrine Biosciences 15.43 Bn 15.04 Bn 935.80 Mn 389.80 Mn
8 Elanco Animal Health 12.02 Bn 11.49 Bn 798.00 Mn 530.00 Mn
9 Dr Reddys Laboratories 10.14 Bn 9.98 Bn - 164.00 Mn
10 Planet 13 Holdings 52.64 Mn 36.16 Mn 12.32 Mn 16.48 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 16.48 Mn
Mar 31, 2026 16.26 Mn
Dec 31, 2025 15.58 Mn
Sep 30, 2025 17.18 Mn
Jun 30, 2025 15.85 Mn
Mar 31, 2025 17.61 Mn
Dec 31, 2024 25.44 Mn
Sep 30, 2024 29.46 Mn
Jun 30, 2024 28.72 Mn
Mar 31, 2024 22.82 Mn
Dec 31, 2023 17.28 Mn
Sep 30, 2023 20.49 Mn
Jun 30, 2023 24.46 Mn
Mar 31, 2023 26.92 Mn
Dec 31, 2022 38.79 Mn
Sep 30, 2022 50.88 Mn
Jun 30, 2022 52.62 Mn
Mar 31, 2022 62.14 Mn
Dec 31, 2021 58.59 Mn
Sep 30, 2021 1.62 Mn